Jessica Herzig/LinkedIn
Dec 21, 2025, 13:54
Jessica Herzig on CD86 Expression Correlation with Immune Cell Activation
RPTH Journal shared on LinkedIn:
”Why do some hemophilia A patients develop inhibitors?
This study points to immune activation patterns that depend more on timing, even seasonality, than on the FVIII product itself.
Check out this fascinating study by Jessica Herzig and team here.”
Article: Season-dependent low basal CD86 expression promotes immune cell activation upon treatment with plasma-derived factor Ⅷ products
Authors: Jessica Herzig, Josselyn Azucena Arciniega Martinez, Svenja M. Küster, Eva Ringler, Stefanie Kronhart, Gerrit J. K. Praefcke, Lilija Miller, Martina Anzaghe, Zoe Waibler
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 23, 2026, 18:13Fight4Hematology Supports Research and Empowers the Next Generation – ASH
-
Feb 23, 2026, 17:59Wolfgang Miesbach: Real-World Evidence of Emicizumab on Joint Outcomes in Hemophilia A
-
Feb 23, 2026, 17:56Shiny K Kajal: The Transfusion Reaction We Often Miss
-
Feb 23, 2026, 17:53Radheshyam Meher: Contributing to the Transfusion Evidence Round-Up for International Childhood Cancer Day 2026
-
Feb 23, 2026, 17:46Mahesan Subramaniam: The Physiological Impact of Anger on Immunity
-
Feb 23, 2026, 17:42Bryan Fry: First Evidence That Bothrops atrox Venom Directly Activates Human Factor VII
-
Feb 23, 2026, 17:34Bastu Odoka: Why Blood Should NOT be Left at the Bedside to ‘Warm’
-
Feb 23, 2026, 17:28Henry Burkitt: Patients Are Challenging How the Medicines Policy System Works in England
-
Feb 23, 2026, 16:50Mutaz Al‑Sabah: Interesting Webinar on FH in Women is Now Available to Watch